Pharmaceutical Executive August 8, 2024
In this part of his Pharmaceutical Executive video interview, Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma’s US affiliate, discusses how is LEO Pharma positioning itself to capitalize on the unmet needs, patient centric initiatives, and more.
Given the increasing focus of large pharma companies on specific therapeutic areas, how is LEO Pharma positioning itself to capitalize on the unmet needs in other areas, and what strategies are you employing to ensure long-term success in these spaces?
So large pharma companies typically focus on large brands. You know, typically, they’re in the game of trying to find blockbusters, defined by more than a billion dollars in annual sales. And what we’re doing is really focusing in on one...